Profit before interest, taxes and amortization: mersana.com (MRSN)

Graphic logo of Mersana Therapeutics, Inc. (MRSN)

Mersana Therapeutics (MRSN) develops high-precision molecules for the targeted delivery of toxins into tumors. The company's operations are protected by a global humanitarian consensus, which eliminates geopolitical risks. Revenues are based on the commercialization of ADCs for the treatment of lung and ovarian cancers. The GURU.Markets portal features a chart of absolute EBITDA dynamics, where the figure remains around 0.00.

MRSN Mersana Therapeutics, Inc. Operating profit EBITDA (11/23/2025 - 01/17/2026)

Summary analytical data breakdowns for Mersana Therapeutics (MRSN)

- current quotes and average value forecast:
Stock Quotes Mersana Therapeutics|MRSN - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Mersana Therapeutics Inc|MRSN - Total Company Value
- book capitalization data:
Accounting Value per Share Mersana Therapeutics|MRSN - Book Capitalization|Market-to-Book Ratio mersana.com|MRSN - Aggregate Company Assets
- debt level and financial liquidity data:
Debt to Equity Ratio Mersana Therapeutics|MRSN - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Mersana|MRSN - Company Aggregate Debts|Debts to Book Value Mersana Therapeutics Inc|MRSN - Company Long-Term Debt|Company Short-Term Loans and Borrowings Mersana Therapeutics|Interim Coverage Ratio mersana.com
- earnings and multiples data:
MRSN - Net Profit|Projected Future Earnings Mersana Therapeutics|MRSN - Price to Earnings Ratio|Price to Future Earnings Ratio Mersana|MRSN - PEG Multiple|EV/EBITDA Multiple Mersana|MRSN - Operating profit before deduction of amortization|Earnings per share for the trailing year Mersana Therapeutics|MRSN - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months mersana.com|MRSN - Earnings growth in current year|Expected earnings per share trend next year Mersana Therapeutics
- sales revenue and business income indicators:
MRSN - Revenue and Sales Volume|Company Expected Sales Volume Mersana Therapeutics|MRSN - Price-to-Revenue Ratio|Forward Price to Sales Mersana Therapeutics, Inc.|MRSN - Sales Growth YoY (TTM)
Summary company analytics:Mersana Therapeutics
Flagship merchandise of Mersana

For Mersana Therapeutics (MRSN), given its high dependence on oncology clinical trial outcomes, EBITDA analysis is critical for assessing financial viability amidst binary risks. This metric isolates net operating cash flow by excluding the impact of debt service and taxes, allowing investors to detect revenue degradation before a deep crisis occurs.

Competitors of Mersana Therapeutics (MRSN)

MRUS - Operating profit before deduction of amortization|IMMP - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Anixa Biosciences|Atossa Pharma (ATOS) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Context Therapeutics Inc|BCTX (BriaCell Therapeutics Corp.) - Operating profit EBITDA|Profit before interest, taxes and amortization essapharma.com EPIX|Profit before payment of interest, taxes and amortization qtimaging.com (QTI)